Stabilization of wild-type p53 by hypoxia-inducible factor 1α

Nature

Volumn 392, Issue 6674, 1998, Pages 405-408

  An, Won G ^a   Kanekal, Meera ^a   Simon, M Celeste ^b   Maltepe, Emin ^b   Blagosklonny, Mikhail V ^a   Neckers, Leonard M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT; COBALT CHLORIDE; DEFEROXAMINE; DNA BINDING PROTEIN; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NUCLEAR PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; CELL CULTURE; CELL HYPOXIA; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; MUTATION;

ANIMALS; CELL HYPOXIA; COBALT; DEFEROXAMINE; DNA-BINDING PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MUTATION; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032568150     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/32925     Document Type: Letter

References (23)

1. Graeber, T. G. et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase Checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14, 6264-6277 (1994).
2. Goldberg, M. A., Dunning, S. P. & Bunn, H. F. Regulationofthe erythropoietin gene: evidence thatthe oxygen sensor is aheme protein. Science 242, 1412-1415 (1988).
3. Salceda, S., Beck, I. & Caro, J. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activaiton by hypoxia. Arch. Biochem. Biophys. 384, 389-394 (1996).
4. Gradin, K. et al. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell Biol. 16, 5221-5231 (1996).
5. Guillemin, K. & Krasnow, M. A. The hypoxic response: huffing and HIFing. Cell 89, 9-12 (1997).
6. Wang, G.L. & Semenza, G. L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-bindingactivity: implicaitons for model ofhypoxia signal transduction. Blood 82, 3610-3615 (1993).
7. Wang, G.L. & Semenza, G. L. Characterization of hypoxia-inducible factor 1 and regulation ofDNA binding activity by hypoxia. J. Biol. Chem. 268, 21513-21518 (1993).
8. Minchenko, A., Salceda, S., Bauer, T. & Caro, J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol. Biol. Res. 40, 35-39 (1994).
9. Levy, A. P., Levy, N. S., Wegner, S. & Goldberg, M. A. Transcriptional regulation of the rat vascular endothelial growth factor gene byhypoxia. J. Biol. Chem. 270, 13333-13340 (1995).
10. Hoffman, E. C. et al. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252, 954-958 (1991).
11. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C.A. & Simon, M. C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lackingtheproteinARNT. Nature 386, 403-407 (1997).
12. Wang, G. L. & Semenza, G. L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl Acad. Sci. USA 90, 4304-4308 (1993).
13. Wang, G.L., Jiang, B.-H., Rue, E.A. & Semenza, G.L. Hypoxia-inducible factor 1 isabasic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 92, 5510-5514 (1995).
14. Wang, G. L. & Semenza, G. L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237 (1995).
15. Wood, S. M., Gleadle, J. M., Pugh, C. W., Hankinson, O. & Ratcliffe, P. J. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction ofgene expression. J. Biol. Chem. 271, 15117-15123 (1996).
16. Kallio, P. J., Pongratz, I., Gradin, K., Mc Guire, J. & Poellinger, L. Activaiton ofhypoxia-inducible factor 1a: posttranscriptional regulation and conformational change by recruitment ofthe Arnt transcription factor. Proc. Natl Acad. Sci. USA 94, 5667-5672 (1997).
17. Maki, C. G., Huibregtse, J. & Howley, P. M. In vivo ubiquitination and proteasome-mediated degradation ofp53. Cancer Res. 56, 2649-2654 (1996).
18. Whitesell, L. et al. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo. Oncogene 14, 2809-2816 (1997).
19. Andrews, N. & Faller, D. A rapid micropreparation technique for extraction ofDNA-bindingproteins from limiting numbers of mammalian cells. Nucleic Acids. Res. 19, 2499 (1991).
20. Blagosklonny, M., Toretsky, J. & Neckers, L. Geldanamycin selectively destabilizes and conforma-tionally alters mutatedp53. Oncogene 11, 933-939 (1995).
21. Arany, Z. et al. An essential role for p300/CPB inthe cellular response to hypoxia. Proc. Natl Acad. Sci. USA 93, 12969-12973 (1996).
22. Huang, L. E., Arany, Z., Livingston, D. M. & Bunn, H. F. Activation ofhypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its a subunit. J. Biol. Chem. 271, 32253-32259 (1996).
23. El-Deiry, W.S., etal. WAF1, apotential mediator ofp53 tumor suppression. Cell 75, 817-825 (1993).